A sell-off in technology stocks intensified Friday, wiping out the Nasdaq Composite’s gains for the year, as investors continued to pull money out of the once high-flying AI trade.
The S&P fell 2.1%, on track for a seventh day of losses – its longest losing streak since February 2020, when Wall Street started bracing for what became the Covid pandemic.
The Nasdaq faced even steeper losses on Friday, dropping 3.6%. It is now down almost 1% for the year.
Even Anthropic’s blockbuster stock market debut quickly lost its shine Friday, with shares plunging 13%. They’re now trading around $84.40, just above the company’s IPO of $83.
“There is a real exodus out of tech stocks,” said Steve Sosnick, chief strategist at Interactive Brokers. “Buy the dip has been taking a back seat to sell the rally – or just sell.”
Losses were less extreme for the Dow, which retreated just 0.5%, cushioned by gains in stocks in other sectors, including healthcare and consumer staples. Even so, both it and the S&P 500 dipped into correction territory Friday, after sliding 10% from their respective peaks on August 5 and October 6.
All together, all three indexes are on track for their worst week since early April 2025, when President Donald Trump’s tariff plans rocked global markets.
Stocks associated with the AI trade have been in a serious rough patch for weeks now. But with Anthropic’s buzzy IPO now in the rear-view mirror, traders’ concerns about the broader AI trade are once again coming to the fore.
Investors are grappling with a bevy of concerns, from uncertainty over how newly elected Democratic governors will impact the pace of the data center buildout to uncertainty about the future of Nvidia’s role in powering the AI industry’s growth after CEO Jensen Huang resigned.
“There is a fear that maybe there is too much froth and enthusiasm in the tech bet given all the risks out there,” said David Kelly, chief global strategist at JPMorgan Asset Management.
Kelly noted that corrections are “inevitable” and there is “nothing particularly ominous” about a correction given how much US stocks have rallied in recent years.
“This is not a fatal illness. It’s not even the flu. At the moment, it looks like a mild cold, and it should be over in a week or two,” he said.
Another growing concern for investors: Companies are spending hundreds of billions of dollars on the AI buildout, using their own cash and also tapping the debt and equity markets to raise more capital.
For awhile, investors cheered the AI spending. But now, they’re getting more serious about demanding evidence of return on investment.
“The market was already questioning some of the cost-benefit analysis … and you’re coming off of relatively euphoric levels. Put all that together, that’s a lot for the market to bear,” Sosnick at Interactive Brokers told CNN.